Transgene Biotek Auditor Resignation

Resignation Date: September 22, 2026
Auditor: M/s. Vasavi & Co., Chartered Accountants

Reader Takeaway: Auditor resignation due to time constraints; monitor company disclosures for the upcoming appointment of a successor auditor.

What just happened

Transgene Biotek Ltd has officially notified the stock exchange that its statutory auditor, M/s. Vasavi & Co., has resigned from the position. The resignation letter was submitted on September 22, 2026, and is effective immediately. The auditor, registered under Firm Registration Number 020965S, indicated they could no longer dedicate sufficient time to the company's audit requirements.

Why this matters

The resignation of a statutory auditor is a significant governance event for public companies. Investors rely on the independent verification provided by the auditor to ensure the accuracy and transparency of financial statements. While the firm cited administrative reasons, the vacancy creates a temporary gap in the oversight process that the company must now address under the Companies Act, 2013.

What changes now

Transgene Biotek Ltd must now initiate the process to appoint a new statutory auditor. The company is required to follow regulatory guidelines under the Companies Act and SEBI listing regulations to fill the vacancy. Investors should monitor subsequent exchange filings for the formal announcement of the new appointment to evaluate the transition.

What to track next

Watch for the announcement of the new auditor appointment. Market participants will be looking for a reputable replacement to restore full oversight and ensure that quarterly and annual financial filings proceed without disruption.